Response to PD1 inhibition in conventional chondrosarcoma

BACKGROUND: Chondrosarcoma is one of the most common malignant bone tumors in adults. Conventional chondrosarcoma represents around 85% of all chondrosarcomas and is notoriously difficult to treat with chemotherapy. CASE PRESENTATION: We describe a 67-year-old man with metastatic conventional chondr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Immunother Cancer
Egile Nagusiak: Wagner, Michael J., Ricciotti, Robert W., Mantilla, Jose, Loggers, Elizabeth T., Pollack, Seth M., Cranmer, Lee D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6156853/
https://ncbi.nlm.nih.gov/pubmed/30253794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0413-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak